Nora Volkow

Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
NIDA Director Nora Volkow Calls Regulating Cannabis 'Crucial' As More States Legalize It
NIDA Study Finds Young Men At Higher Risk Of Schizophrenia Linked With Cannabis Use Disorder

Nora Volkow Recent News

Safe Drug Consumption Sites Possible In US, New Zealand's Aerial Weed Busts, Ireland Looks At Legalizing Marijuana
Here's How Safe Drug Consumption Sites Could Get Green Light
Top Federal Official: Safe Consumption Sites Save Lives, More Cannabis & Psychedelics Research Needed
Safe consumption sites have proven useful in saving patients from overdosing, a top federal drug official said.
ICYMI: There's No Proof Smoking Weed Occasionally Is Harmful: NIDA Director Dr. Nora Volkow Agrees
This article was originally published in December 2021.
CDC: Alcohol & Cannabis Most Common Substances For Which People Seek Treatment In Times Of Mental Health Crises
The Centers for Disease Control and Prevention (CDC) recently released its Morbidity and Mortality Weekly Report revealing that the most common substances for which adult Americans have sought substance misuse treatment in 2019 were alcohol, cannabis, and a combina
Occasional Cannabis Use Doesn't Impair Physical Health Of Young Adults, Twin Study Confirms
How does occasional cannabis use affect our health? A frequent question, for which there is no simple and conclusive answer. The impact on our overall physical and mental health has yet to be fully researched. The federal status of cannabis as a Schedule I drug severely limits scientific studies on this important topic.
Marijuana & Brain: Can Cannabis Cause Psychiatric Disorders? Neuroscientist Weighs In
Our brains can be affected by what we consume and what we are exposed to, says neuroscientist Dr. Yasmin Hurd in an online presentation “Neuroscience and Cannabis: Implications for Law and Policy” she gave on 4/20, which was part of the Project on Law and Applied Neurosci
Top Officials Acknowledge Difficulties Of Psychedelics Research In The U.S.
During an event organized by the National Academies of Sciences, Engineering and Medicine, titled “Exploring Psychedelics & Entactogens to Treat Psychiatric Disorders,” two officials noted the challenges scientists face in conducting research into Schedule I substances such as psychedelics,
Federal Cannabis Legalization Bill Could Get Floor Vote In The House, Sooner Rather Than Later
Marijuana Opportunity, Reinvestment and Expungement (MORE) Act is poised to end up on the House floor next week, reported Marijuana Moment.
Seattle Physician Launches Push To Reschedule Psilocybin For Medical Use
The DEA recently increased its quota for psilocybin for 2022, as well as for the legal production of psychedelic drugs such as MDMA and DMT, in response to heightened demand and
DEA Ends 5-Decade Federal Monopoly On Research Cannabis Production, Approves Two Companies To Harvest Plants
The Drug Enforcement Administration (DEA) finally authorized two cannabis companies to harvest marijuana for research purposes, 
Cannabis Use Among Teens Drastically Declined, Confirms Government-Funded Study
Data released on Wednesday from the University of Michigan’s annual Monitoring the Future (MTF) survey has shown an unprecedented year-over-year decline in young people’s use of marijuana and other controlled substances.